BILL ANALYSIS

HR7363

BEARISH

ICE Out of Our Faces Act

HR7363 (ICE Out of Our Faces Act) has been assessed with a bearish outlook for investors. This legislation directly affects Axon Enterprise ($AXON). The primary sectors impacted are Technology and Transportation. View the full bill text on Congress.gov.

bearish

Market Sentiment

1

Affected Stocks

2

Sectors Impacted

Key Takeaways for Investors

1

HR 7363 is an early-stage bill with low passage probability; no funding is authorized.

2

Axon Enterprise ($AXON) faces a mild bearish risk from potential biometric software sales to immigration agencies, but this is a tiny revenue fraction.

3

No major market shifts expected; the bill is largely symbolic at this point.

How HR7363 Affects the Market

The bill has no near-term market implications. If passed, it would create a regulatory barrier for any biometric surveillance vendor selling to immigration enforcement, but passage probability is low. Axon ($AXON) has a small bearish exposure but not material enough to change investment theses. No other public companies face significant impact.

Bill Details

MetricValue
Bill NumberHR7363
Market Sentimentbearish
Event Date
Affected SectorsTechnology, Transportation
Affected StocksAxon Enterprise ($AXON)
SourceView on Congress.gov →

Summary

HR 7363, the 'ICE Out of Our Faces Act', is an early-stage bill prohibiting DHS immigration enforcement from using facial recognition and biometric surveillance. It is in the earliest legislative phase (referred to subcommittee) with no funding authorization, minimal passage probability given its cosponsor count and lack of committee leadership support. Market impact is negligible for most companies; Axon has a tiny bearish exposure to the extent their biometric software sells to immigration agencies.

Full AI Market Analysis

1) On February 4, 2026, Representative Pramila Jayapal (D-WA) introduced HR 7363, titled the 'ICE Out of Our Faces Act.' The bill was referred to the Judiciary and Homeland Security Committees and subsequently to the Subcommittee on Border Security and Enforcement. It is in the earliest stage of the legislative process with no hearings or markups scheduled. The bill has 9 cosponsors, all presumably Democrats, and lacks any Republican support or chair sponsorship, indicating very low passage probability in the Republican-controlled 119th Congress. A companion bill (S3779) exists in the Senate but similarly is early-stage. 2) This is a prohibition bill, not an authorization or appropriation bill. It contains no funding provisions. It would restrict the use of existing funds rather than allocate new money. As such, the congressional budget impact is effectively zero. The financial effect on the private sector is limited to any companies selling biometric surveillance systems specifically to DHS immigration enforcement agencies (CBP and ICE). 3) There are no related market signals, other legislation, or federal procurement actions in the provided data that converge with this bill. The bill stands alone and is not part of a broader regulatory wave. The administration's stance on facial recognition is not specified, and no presidential action or executive order is provided for context. 4) The only clearly affected public company is Axon Enterprise ($AXON), which sells body cameras and accompanying cloud-based biometric software to law enforcement. Axon has contracts with CBP and ICE for body cameras and cloud evidence services. While the core camera hardware and basic evidence storage are not restricted, the bill would ban immigration agencies from using Axon's facial recognition and AI analytics features. However, Axon's total revenue from immigration enforcement biometrics is a very small fraction of its ~$2 billion annual revenue. Companies like Clearview AI are private and not publicly traded. Large tech companies (MSFT, GOOGL, AMZN) offer facial recognition services through cloud platforms but their exposure to DHS immigration enforcement is minimal relative to their total revenue; the bill would not materially impact them. 5) The bill faces a long and uncertain path: referral to subcommittee, possible hearings, committee markups, House floor vote, Senate companion process, conference committee, and presidential signature or veto. Given the current partisan environment and lack of committee leadership support, the bill is unlikely to advance beyond subcommittee. No timeline is predictable.

Stocks Affected by HR7363

Sectors Impacted by HR7363

Related Technology Legislation

Understand the Terms

Free — no credit card

Know which stocks HR7363 moves — before the market does

HillSignal scores every bill, federal contract, and insider filing for market impact and emails you the high-conviction ones. Free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →